A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1992
10/28/1992	CN1065729A Monoclonal antibodies
10/28/1992	CN1018845B 病毒疫苗 Virus vaccine
10/27/1992	WO1992019970A1 Methods to detect and treat diseases caused by bacterial allergens
10/27/1992	US5158939 Administering a nontoxic lipopolysaccharide from rhodopseudomonas which negate the inhibitory effects of thymus derived T suppressor cells
10/27/1992	US5158886 Monoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereof
10/27/1992	US5158885 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
10/27/1992	US5158769 Genetic engineering; polypeptide protective coating for vaccine
10/27/1992	US5157894 Orientation and loading device for vials in general and syringe vials in particular
10/27/1992	CA2109088A1 Methods to detect and treat diseases caused by bacterial allergens
10/27/1992	CA1309558C D-gl conjugate therapy
10/27/1992	CA1309340C Cationized antibodies for delivery through the blood-brain barrier
10/24/1992	CA2066810A1 Cytomodulating conjugates of members of specific binding pairs
10/22/1992	DE4112743A1 Peptide(s) for hepatitis-C virus detection
10/21/1992	EP0509553A1 Anti-lymphotoxin antibody, its production and use
10/21/1992	EP0509008A1 Biomass for the production of viruses/virus antigens.
10/21/1992	EP0509006A1 Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
10/21/1992	EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/21/1992	CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
10/21/1992	CN1065465A Polyethylene protein conjugates
10/20/1992	WO1992018618A1 Modified plant viruses as vectors
10/20/1992	US5157112 Antibodies immunoreactive with the T-cell growth factor, P40
10/20/1992	US5157104 Antitumor, anticarcinogenic agents
10/20/1992	US5157020 Two covalently bonded peptides
10/20/1992	US5156977 Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use
10/20/1992	US5156970 Methods of viral propagation and gene expression
10/20/1992	US5156958 Gene encoding a 30 kilodalton outer membrane protein of bordetella pertussis and method of recombinant production of said protein
10/20/1992	US5156949 Immunoassays for antibody to human immunodeficiency virus using recombinant antigens
10/20/1992	US5156841 Anti-tumor vaccine
10/20/1992	CA2065658A1 Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
10/20/1992	CA2064933A1 Carrier protein
10/20/1992	CA1309039C Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
10/19/1992	WO1992018540A1 Anti-human immunodeficiency virus recombinant antibodies
10/15/1992	WO1992017602A1 Parathyroid hormone receptor and dna encoding same
10/15/1992	WO1992017590A1 Therapeutic and preventive vaccines for hiv
10/15/1992	WO1992017589A1 Method for producing a subunit vaccine against porcine parvovirus
10/15/1992	WO1992017587A1 Bordetella bronchiseptica outer membrane antigen
10/15/1992	WO1992017567A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	WO1992017505A1 Monoclonal antibodies to stem cell factor receptors
10/15/1992	WO1992017497A1 Human pf4a receptors and their use
10/15/1992	WO1992017493A2 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
10/15/1992	WO1992017210A1 Novel protein polycation conjugates
10/15/1992	WO1992017206A1 Wound healing
10/15/1992	WO1992017205A1 Method for producing a subunit vaccine against the canine parvovirus and other related viruses
10/15/1992	WO1992017204A1 Circumsporozoite protein of plasmodium reichenowi and vaccine for human malaria
10/15/1992	WO1992017199A1 Compositions and methods for treating small cell and nonsmall cell lung cancers
10/15/1992	WO1992017198A1 Dna and amino acid sequence specific for natural killer cells
10/15/1992	WO1992017165A1 A single dose vaccination system
10/15/1992	WO1992011367A3 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
10/15/1992	WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity
10/15/1992	CA2407304A1 Human pf4a receptors and their use
10/15/1992	CA2116362A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	CA2083949A1 Therapeutic and preventive vaccines for hiv
10/14/1992	EP0508809A1 Proteinaceous lipid-containing particles
10/14/1992	EP0508783A1 Attenuated poliovirus and vaccines thereof
10/14/1992	EP0508776A1 CA 195-like immunoreactive antigen from human amniotic fluid
10/14/1992	EP0508282A2 Anti-idiotypic monoclonal antibodies
10/14/1992	EP0508221A1 Somatostatin receptor
10/14/1992	EP0507948A1 Monoclonal antibody, hybridomas, their production and use
10/14/1992	EP0507868A1 Diagnostic probe for detecting human stomach cancer
10/14/1992	EP0507867A1 Papillomavirus (hpv63) probe, particularly for the in vitro diagnosis of papillomavirus infections, possibly accompanied by genital neoplasias, and products genetically and immunologically linked to this papillomavirus
10/14/1992	EP0303681B1 Immunosuppression in immunotoxin based human therapy
10/14/1992	EP0208743B1 Polydispersed native pseudomonas-flagella (h)-antigens (fag) and methods for their preparation
10/14/1992	CN1065205A Preventive agent against infectious disease of crustacea
10/14/1992	CN1018649B Immunoglobulin conjugates
10/13/1992	US5155218 Dna encoding human 5-ht1d receptors
10/13/1992	US5155212 Substituted phencyclidine compound linked to polyamino acid
10/13/1992	US5155020 Recombinant poxvirus host range selection system
10/13/1992	US5154924 Method for delivering a neuropharmaceutical agent across the blood brain barrier to the brain of a host
10/13/1992	US5154923 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions
10/13/1992	CA1308711C Derivatives of monophosphoryl lipid a and process for preparation
10/13/1992	CA1308677C Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
10/13/1992	CA1308676C Anti-human igg (immunoglobulin g) monoclonal antibody and process for preparing the same
10/11/1992	WO1992018641A1 Interleukin-8 receptors and related molecules and methods
10/11/1992	WO1992018621A1 Proteinaceous lipid-containing particles
10/11/1992	WO1992018620A1 Attenuated poliovirus and vaccines thereof
10/11/1992	CA2108141A1 Attenuated poliovirus and vaccines thereof
10/11/1992	CA2107879A1 Proteinaceous lipid-containing particles
10/11/1992	CA2107682A1 Interleukin-8 receptors and related molecules and methods
10/11/1992	CA2042318A1 Attenuated viruses
10/10/1992	WO1992018535A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination
10/10/1992	CA2081900A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination
10/10/1992	CA2062675A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination
10/07/1992	EP0507615A1 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
10/07/1992	EP0507187A1 Method for inhibiting pulmonary oxygen toxicity
10/07/1992	EP0507179A2 Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines
10/07/1992	EP0506945A1 Method of gene transfer using retrotransposons
10/07/1992	EP0506893A1 Diagnosis and treatment of diseases
10/07/1992	EP0506890A1 Recombinant thyrotropin receptor
10/07/1992	EP0506868A1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine.
10/07/1992	EP0506855A1 Cytokine antibody for the treatment of sepsis
10/07/1992	EP0506854A1 An improved toxin for construction of immunotoxins
10/07/1992	EP0506815A1 Mucin nucleotides
10/07/1992	EP0506785A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
10/07/1992	EP0506766A1 Hepatocellular carcinoma oncogene
10/07/1992	EP0506756A1 Transformed cell lines
10/07/1992	EP0506755A1 Polypeptides having serine protease inhibitor activity and dna coding therefor
10/07/1992	EP0506714A1 Matrix with adherently bound cells and process for producing viruses/virus antigens.
10/07/1992	EP0201579B1 Preparations containing a microflora having increased adhesive effect
10/07/1992	EP0185092B1 Process for preparing 5'-guanylic acid
10/06/1992	US5153312 Respiratory system disorders

1 ... 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 ... 1823